Caren Deardorf

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Tobin Schilke, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caren Deardorf:

Company Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Director Common Stock 16,300 $543,116 $33.32 11 Jun 2025 Direct
Magenta Therapeutics, Inc. Chief Commercial Officer Common Stock 19,762 $237,144 $12.00 30 Nov 2022 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 10,350 11 Jun 2025 Direct

Insider Reports Filed by Caren Deardorf

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRNX Crinetics Pharmaceuticals, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 07 Jun 2024 2 $0 4 Director 11 Jun 2024, 16:21
CRNX Crinetics Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:00
DNTH Magenta Therapeutics, Inc. 30 Nov 2022 1 +$2,820 4 Chief Commercial Officer 02 Dec 2022, 15:23
DNTH Magenta Therapeutics, Inc. 01 Aug 2022 1 $0 4 Chief Commercial Officer 01 Aug 2022, 21:10
CRNX Crinetics Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:45
DNTH Magenta Therapeutics, Inc. 31 May 2022 1 +$2,970 4 Chief Commercial Officer 06 Jun 2022, 16:05
DNTH Magenta Therapeutics, Inc. 17 May 2022 1 $0 4 Chief Commercial Officer 19 May 2022, 16:17
CRNX Crinetics Pharmaceuticals, Inc. 11 Mar 2022 1 $0 4/A Director 04 Apr 2022, 19:09
CRNX Crinetics Pharmaceuticals, Inc. 11 Mar 2022 0 $0 3 Director 14 Mar 2022, 17:18
DNTH Magenta Therapeutics, Inc. 15 Feb 2022 1 $0 4 Chief Commercial Officer 17 Feb 2022, 16:20
DNTH Magenta Therapeutics, Inc. 16 Sep 2021 1 -$41,982 4 Chief Commercial Officer 20 Sep 2021, 17:02
DNTH Magenta Therapeutics, Inc. 14 Sep 2021 1 $0 4 Chief Commercial Officer 16 Sep 2021, 19:41
DNTH Magenta Therapeutics, Inc. 06 Jul 2021 1 $0 4 Chief Commercial Officer 08 Jul 2021, 16:33
DNTH Magenta Therapeutics, Inc. 06 Jul 2021 0 $0 3 Chief Commercial Officer 08 Jul 2021, 16:32